Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML (Q58814184)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 September 2014

Language	Label	Description	Also known as
English	Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML	scientific article published on 22 September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Raphaël Porcher

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

M Sébert

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

M Robin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

L Adès

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

N Boissel

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

E Raffoux

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

A Xhaard

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

N Dhedin

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

J Larghero

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

C Himberlin

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

A Delmer

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

P Fenaux

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

H Dombret

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

G Socié

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

R P de Latour

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

0 references

publication date

22 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

74-81

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective s

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Defining the intensity of conditioning regimens: working definitions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

The Analysis of Failure Times in the Presence of Competing Risks

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Marginal structural models and causal inference in epidemiology

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

The EBMT risk score

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Measurement of Th1, Th2 cytokines and white cell count in childhood haemoglobinopathies with uncomplicated malaria infection

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Haematopoietic cell transplantation as immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.199

21 January 2018

Limits of HLA mismatching in unrelated hematopoietic cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25243624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25243624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25243624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25243624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://pubmed.ncbi.nlm.nih.gov/25243624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute leukemia in adults: novel allogeneic transplant strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25243624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25243624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25243624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/25243624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BMT.2014.199

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243624%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58814184&oldid=2234892829"